Compounds > 2-azabicyclo(2.2.1)hept-5-en-3-one
Page last updated: 2024-12-09

2-azabicyclo(2.2.1)hept-5-en-3-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-azabicyclo(2.2.1)hept-5-en-3-one: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID548678
SCHEMBL ID548616
MeSH IDM0172621

Synonyms (43)

Synonym
3-azabicyclo[2.2.1]hept-5-en-2-one
49805-30-3
A1359
2-azabicyclo[2.2.1]hept-5-en-3-one
EN300-82926
(-)-2-azabicyclo[2.2.1]hept-5-en-3-one
A827858
AKOS006223009
2-azabicyclo(2.2.1)hept-5-en-3-one
FT-0643143
FT-0600312
FT-0601151
(-)-(1r,4s)-2-azabicyclo[2.2.1]hept-5-en-3-one
SCHEMBL548616
2-azabicyclo[2.2.1]hept-5-en-3-one #
2-azabicyclo[2.2.1]hept-5-en-3-one, (1s)-
J-500009
(-)-2-azabicyclo[2,2,1]hept-5-en-3-one
(+/-)-2-azabicyclo [2.2.1]hept-5-en-3-one
(+/-)-2-azabicyclo[2.2.1 ]hept-5-en-3-one
(-)-2-azabicyclo [2.2.1]hept-5-en-3-one
(-)-2-azabicyclo [2.2.1] hept-5-en-3one
racemic 2-aza bicyclo[2.2.1]hept-5-ene-3-one
J-650015
(1r)-(-)-2-azabicyclo[2,2,1]hept-5-en-3-one
Q-200006
J-650014
J-650392
azabicyclo[2.2.1]hept-5-en-3-one
rac 2-azabicyclo[2.2.1]hept-5-en-3-one
(r,s)-2-azabicyclo(2.2.1)hept-5-en-3-one
ec 421-830-3
AC-6114
3-oxo-2-azabicyclo[2.2.1]hept-5-ene
SY004961
CS-W019811
DTXSID40868505
61865-48-3
SY096758
DS-11069
SB18483
SB18484
SB11075
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.14 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
azides
Azides: Organic or inorganic compounds that contain the -N3 group.. azide : Any nitrogen molecular entity containing the group -N3.		2.0110pseudohalide anionmitochondrial respiratory-chain inhibitor
adenosine
quinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlit		2.0110adenosines;
purines D-ribonucleoside		analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
ConditionIndicatedRelationship StrengthStudiesTrials